Similarly, in BRAF mutantcolorectal cancers, feedback activation of EGFR-dependent signaling attenuates theconsequences of mutant BRAF inhibition, suppressing the apoptotic effect (Corcoran et al., 2012; Prahallad et al., 2012). This evidence concerns the gene EGFR and cancer.